NasdaqGM - Nasdaq Real Time Price USD

Aspire Biopharma Holdings, Inc. (ASBP)

0.3565
+0.0212
+(6.32%)
At close: May 9 at 4:00:00 PM EDT
0.3519
-0.00
(-1.29%)
After hours: May 9 at 4:07:18 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
Cost of Revenue
--
--
0
0
Gross Profit
--
--
0
0
Operating Expense
3,088.6710
3,088.6710
1,340.1680
596.4910
Operating Income
-3,088.6710
-3,088.6710
-1,340.1680
-596.4910
Net Non Operating Interest Income Expense
-342.9480
-342.9480
5,804.2470
0
Other Income Expense
-9,105.8530
-9,105.8530
--
--
Pretax Income
-12,537.4720
-12,537.4720
4,464.0790
-596.4910
Tax Provision
--
--
0.4810
0.6260
Net Income Common Stockholders
-12,537.4720
-12,537.4720
4,464.0790
-597.1170
Diluted NI Available to Com Stockholders
-12,537.4720
-12,537.4720
4,464.0790
-597.1170
Basic EPS
-0.27
--
0.10
-0.01
Diluted EPS
-0.27
--
0.10
-0.01
Basic Average Shares
46,007.5130
--
46,007.5130
46,007.5130
Diluted Average Shares
46,007.5130
--
46,007.5130
46,007.5130
Total Expenses
3,088.6710
3,088.6710
1,340.1680
596.4910
Net Income from Continuing & Discontinued Operation
-12,537.4720
-12,537.4720
4,464.0790
-597.1170
Normalized Income
-12,537.4720
-12,537.4720
4,464.0790
-597.1170
Interest Income
548.6760
548.6760
5,813.2130
--
Interest Expense
891.6240
891.6240
8.9660
0
Net Interest Income
-342.9480
-342.9480
5,804.2470
0
EBIT
-11,645.8480
-11,645.8480
4,473.0450
-596.4910
EBITDA
-11,645.8480
-11,645.8480
4,473.0450
-596.4910
Reconciled Cost of Revenue
--
--
0
0
Reconciled Depreciation
0
0
0
0
Net Income from Continuing Operation Net Minority Interest
-12,537.4720
-12,537.4720
4,464.0790
-597.1170
Normalized EBITDA
-11,645.8480
-11,645.8480
4,473.0450
-596.4910
Tax Rate for Calcs
0
0
0.0002
0.0002
Tax Effect of Unusual Items
0
0
0
0
12/31/2022 - 4/11/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ATNF 180 Life Sciences Corp.
1.0900
-0.91%
 
AEON AEON Biopharma, Inc.
0.4734
+3.36%
 
SNSE Sensei Biotherapeutics, Inc.
0.3600
-4.41%
 
ACXP Acurx Pharmaceuticals, Inc.
0.3600
-4.79%
 
SILO Silo Pharma, Inc.
0.8149
0.00%
 
ALZN Alzamend Neuro, Inc.
0.6581
+21.87%
 
KLTO Klotho Neurosciences, Inc.
0.1661
+3.81%
 
KLRS Kalaris Therapeutics, Inc.
3.4800
-9.61%
 
ABP Abpro Holdings, Inc.
0.2000
+3.09%
 
OVID Ovid Therapeutics Inc.
0.2901
-1.33%